APOE and Alzheimer disease: Increase of SYNJ1 mRNA in APOEε4 carriers in our AD cohort is consistent with the previously reported upregulation of SYNJ1 mRNA in APOEε4 knock-in mouse brains and human APOEε4 carriers [61], supporting the hypothesis that SYNJ1 is involved in the APOE-related AD susceptibility.